Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammation and atherosclerosis.

Peter Libby1, Paul M Ridker, Attilio Maseri

  • 1Leducq Center for Cardiovascular Research, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. plibby@rics.bwh.harvard.edu

Circulation
|March 6, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leukocyte-shed soluble CD31 unmasks coronary disease in low-risk outliers and provides source-specific inflammatory signatures of vulnerable plaques.

Atherosclerosis·2025
Same author

Differential Proteomics of Cardiovascular Risk and Coronary Artery Disease in Humans.

Frontiers in cardiovascular medicine·2022
Same author

Mannose as a biomarker of coronary artery disease: Angiographic evidence and clinical significance.

International journal of cardiology·2021
Same author

Metabolomic correlates of coronary atherosclerosis, cardiovascular risk, both or neither. Results of the 2 × 2 phenotypic CAPIRE study.

International journal of cardiology·2021
Same author

Family history in first degree relatives of patients with premature cardiovascular disease.

International journal of cardiology·2021
Same author

Erratum. Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study. Diabetes Care 2020;43:843-851.

Diabetes care·2021
Same journal

Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy: A Scientific Statement From the American Heart Association.

Circulation·2026
Same journal

A Bundle to Frame Guidelines and American Heart Association Statements.

Circulation·2026
Same journal

<i>Circulation</i> Editors and Editorial Board.

Circulation·2026
Same journal

A New <i>Circulation</i>, For You.

Circulation·2026
Same journal

Cardiovascular Risk Reduction With GLP-1 RA Drugs.

Circulation·2026
Same journal

Obesity, Severe Obesity, and Abdominal Obesity in US Youth and Adults From 1999 to 2023.

Circulation·2026
See all related articles

Inflammation plays a key role in atherosclerosis, from its start to its complications. Measuring inflammatory markers like C-reactive protein helps predict patient outcomes and guide therapy for this widespread disease.

Area of Science:

  • Cardiovascular Science
  • Inflammation Biology

Background:

  • Atherosclerosis was once viewed as a lipid storage issue.
  • Emerging research reveals inflammation is central to all disease stages, including thrombotic complications.

Purpose of the Study:

  • To explore the role of inflammation in atherosclerosis.
  • To link basic science findings on inflammation to clinical applications in human patients.

Main Methods:

  • Review of recent basic science advances in atherogenesis.
  • Analysis of clinical studies examining inflammatory markers and patient outcomes.

Main Results:

  • Inflammation is integral to atherosclerosis initiation, progression, and thrombotic events.
  • Elevated inflammatory markers predict outcomes in acute coronary syndromes.

Related Experiment Videos

  • C-reactive protein levels identify atherosclerosis risk, complementing traditional factors.
  • Statins reduce coronary risk partly via anti-inflammatory effects, independent of LDL reduction.

    • Conclusions:

    • Inflammation is a critical mediator in atherosclerosis, linking risk factors to disease mechanisms.
    • Clinical application of inflammatory insights aids in risk stratification and targeted therapies.
    • Understanding inflammation offers new strategies for managing this global health challenge.